ArticleScientific reports2026
Emergence of virulent ESBL-producing Escherichia coli in meat with human health implications and control using liposomal cinnamon, oregano, and clove within a One Health framework.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cross-Species Dissemination of Pandrug-ResistantMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Transmission of extended-spectrum β-lactamases-producing (ESBL) Escherichia coli from meat and meat by-products to humans has emerged as a major public health issue, requiring a One Health framework to address this menace. Hence, we investigated the phylotypes, antimicrobial resistance profiles, and virulotypes of E. coli isolates from chicken meat, beef burger, and human stool samples, besides investigating the in vitro antimicrobial and antivirulence efficacies of liposomal cinnamon, oregano, and clove essential oils (LCOC). A total of 90 isolates (28.1%) were phenotypically and molecularly identified as E. coli, and they were classified into four phylogenetic groups: B1, B2, A, and D (40, 35.6, 14.4, and 10%, respectively). The majority of the isolates were multidrug-resistant (MDR) (97.8%), with remarkable resistance against ampicillin, tetracycline, and cefotaxime (95.6, 84.4, and 81.1%, respectively). The blaTEM, tetA, aadA1, and blaCTX-M were the most prevalent resistance genes (96.7, 85.6, 81.1, and 81.1%, respectively). Virulotyping revealed that 70% of the isolates were multi-virulent, with iroN being the most prevalent one (92.2%). LCOC demonstrated in vitro antibacterial and antivirulence properties via inhibiting the growth of MDR, multi-virulent, and ESBL meat E. coli isolates and downregulating the expression of their investigated virulence genes. Concisely, the observed 28.1% prevalence of ESBL-producing E. coli indicates a notable public health concern associated with meat contamination. Our findings demonstrate that LCOC exhibited antimicrobial activity against the tested E. coli isolates and may help reduce their antibiotic resistance and virulence potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.